Swiss Banks Stock News

SWX:NOVN
SWX:NOVNPharmaceuticals

Novartis Kidney Data And Actinium Deal Shape Long Term Growth Story

Novartis (SWX:NOVN) reported positive final Phase III ALIGN results for Vanrafia in IgA nephropathy, indicating meaningful benefits in kidney function. The company also signed a long term supply agreement with Niowave for Actinium 225 to support its radioligand therapy portfolio. For investors watching SWX:NOVN, these updates come against a backdrop of solid recent share performance. The stock closed at CHF125.14 and is up 4.3% over the past week, 7.8% over the past month, 15.3% year to...
SWX:SCHN
SWX:SCHNMachinery

Schindler Holding (SWX:SCHN) Margin Improvement Tests Premium Valuation Narratives

Schindler Holding (SWX:SCHN) has wrapped up FY 2025 with fourth quarter revenue of CHF 2.8b and basic EPS of CHF 2.44, alongside trailing twelve month revenue of CHF 10.9b and EPS of CHF 9.48 that sit against earnings growth of 12.9% over the past year. The company has seen quarterly revenue move from CHF 2.9b in Q4 2024 to CHF 2.8b in Q4 2025, while basic EPS shifted from CHF 1.81 to CHF 2.44 over the same period, setting up a story where investors will be weighing solid earnings progress...
SWX:NESN
SWX:NESNFood

Assessing Nestlé (SWX:NESN) Valuation As Baby Formula Recall Drives 24 Hour Production

Nestlé (SWX:NESN) is in focus after a global baby formula recall linked to the cereulide toxin pushed the company to run five European factories 24 hours a day to support supply and consumer confidence. See our latest analysis for Nestlé. The recent safety driven ramp up in baby formula output comes after a period where momentum has been fairly muted. The share price return is 4.1% year to date, but the three year total shareholder return has declined by 20.1%, pointing to a company still...
SWX:UBSG
SWX:UBSGCapital Markets

Is UBS Group (SWX:UBSG) Trading Legal Risks for Efficiency in Its India Expansion Strategy?

In recent days UBS Group has moved to reshape its operations, announcing plans to build out a new global capability centre in Hyderabad, India that is expected to hire close to 3,000 professionals, alongside workforce reductions in Switzerland linked to the Credit Suisse integration, while also facing a US$5.5 million arbitration payout to former client Kyle Blackmon. Together, this expansion of UBS’s technology and operations footprint in India and the legal setback in the Blackmon case...
SWX:LOGN
SWX:LOGNTech

How Logitech’s New Value Wireless Headset Launch At Logitech International (SWX:LOGN) Has Changed Its Investment Story

Earlier this month, Logitech International launched the Logitech G325 LIGHTSPEED Wireless Gaming Headset, a US$79.99 wireless device featuring LIGHTSPEED connectivity, 24-bit audio, and cross-platform support for PC, console, and mobile. By packaging higher-end wireless performance, software customization through G HUB, and AI-powered noise reduction into a lower-priced headset, Logitech is targeting value-conscious gamers who still want advanced features. We’ll now examine how this...
SWX:DAE
SWX:DAEMachinery

A Look At Dätwyler Holding (SWX:DAE) Valuation After Earnings Rebound And Affirmed Dividend

Why Dätwyler Holding’s latest earnings and dividend move matter Dätwyler Holding (SWX:DAE) just posted its full year 2025 results, with sales at CHF 1,100.5 million and net income at CHF 80.8 million, alongside an affirmed annual dividend of CHF 3.20 per share. See our latest analysis for Dätwyler Holding. The earnings rebound and affirmed dividend appear to sit behind a recent pick up in momentum, with a 90 day share price return of 20.8% and a 1 year total shareholder return of 27.65%, even...
SWX:SGSN
SWX:SGSNProfessional Services

SGS (SWX:SGSN) Margin Uplift And 15% EPS Growth Test Premium Valuation Narratives

SGS (SWX:SGSN) has wrapped up FY 2025 with second half revenue of CHF3.5b and basic EPS of CHF1.83, while the trailing 12 month figures sit at CHF6.9b of revenue and EPS of CHF3.48, giving investors a clear read on the current earnings run rate. The company has seen revenue move from CHF3.5b and EPS of CHF1.65 in the second half of 2024 to CHF3.4b and EPS of CHF1.64 in the first half of 2025, before landing at the latest CHF3.5b and CHF1.83 print. This sets up a story where profit margins and...
SWX:SCMN
SWX:SCMNTelecom

Swisscom (SWX:SCMN) Margin Compression To 8.4% Tests Bullish Earnings Narratives

Swisscom (SWX:SCMN) closed out FY 2025 with fourth quarter revenue of CHF 3,873 million and basic EPS of CHF 5.45, while trailing twelve month EPS sat at CHF 24.54 on total revenue of CHF 15,048 million. Over recent periods the company has seen quarterly revenue range from CHF 3,687 million to CHF 3,873 million in 2025, with EPS moving between CHF 5.00 and CHF 7.08. This gives investors a clear read on how the top line and per share earnings are tracking into the latest print. With trailing...
SWX:SCHN
SWX:SCHNMachinery

Schindler Holding (SWX:SCHN) Valuation After Strong 2025 Margin Beat Modernization Growth And Extra Dividend Proposal

Why Schindler Holding’s latest earnings matter for shareholders Schindler Holding (SWX:SCHN) has put fresh numbers on the table, reporting a 2025 EBIT margin of 12.6%, stronger modernization activity, and a proposed mix of regular and extraordinary dividends that directly affects shareholder cash returns. See our latest analysis for Schindler Holding. At a share price of CHF273.0, Schindler Holding has seen a 2.63% 1 day share price return after the earnings release, even though the 7 day...
SWX:NESN
SWX:NESNFood

Is Nestlé (SWX:NESN) Offering Opportunity After Mixed Long Term Share Performance

If you are wondering whether Nestlé at around CHF79.34 is offering fair value or a potential bargain, you are in the right place for a clear look at what that price really represents. The stock has returned 1.2% over the last 7 days and 5.5% over the last 30 days, although the 1 year return is a 1.8% decline and the 3 year return sits at a 19.3% decline, with a 7.9% decline over 5 years. Recent coverage has focused on how investors are reassessing large consumer staples companies like...
SWX:DKSH
SWX:DKSHTrade Distributors

A Look At DKSH Holding’s Valuation As The 2026 Earnings Release Puts Margins And Dividend Outlook In Focus

DKSH Holding (SWX:DKSH) heads into its 17 February 2026 earnings release with investors closely watching margins in Healthcare and Consumer Goods, alongside working capital metrics that could influence dividend expectations and near term sentiment. See our latest analysis for DKSH Holding. At a share price of CHF60.8, DKSH Holding has a 90 day share price return of 10.34%. Its 1 year total shareholder return of 10.59% and 3 year total shareholder return of 14.65% suggest recent momentum...
SWX:UBSG
SWX:UBSGCapital Markets

Is UBS Group (SWX:UBSG) Still Attractive After Credit Suisse Acquisition And Recent Share Pullback

If you are wondering whether UBS Group shares still offer value at current levels, you are not alone. This article is designed to help you weigh that up clearly. The stock last closed at CHF32.57, with returns of a 6.4% decline over 7 days, a 14.2% decline over 30 days and a 14.7% decline year to date, while the 1 year return sits at 12% and the 3 and 5 year returns are 74.5% and 166.5% respectively. Recent coverage has focused on UBS Group's role as a major global wealth manager and...
SWX:ROG
SWX:ROGPharmaceuticals

Assessing Roche Holding (SWX:ROG) Valuation After Fenebrutinib Progress And Data Analytics Push

Why fenebrutinib and data analytics matter for Roche Holding stock Roche Holding (SWX:ROG) has put fresh attention on its pipeline after reporting late stage data for its oral MS candidate fenebrutinib and highlighting new data analytics platforms in clinical development. For you as a shareholder or potential investor, these updates link directly to how Roche allocates R&D spending, manages clinical risk and builds potential future revenue sources beyond its currently marketed therapies. See...
SWX:UHR
SWX:UHRLuxury

Assessing Swatch Group (SWX:UHR) Valuation After Weak Earnings And Dividend Confirmation

Earnings setback and dividend affirmation come into focus Swatch Group (SWX:UHR) is in the spotlight after full year 2025 results showed sales of CHF 6,280 million and net income of CHF 3 million, alongside confirmation of an annual dividend of CHF 4.50 per share. See our latest analysis for Swatch Group. The annual results and dividend affirmation arrived alongside strong near term momentum, with a 1 day share price return of 2.43% and a 30 day share price return of 12.53%. However, the 3...